HRT taken for 10 years significantly reduces risk of heart failure and heart attack

HRT therapy has been subject to much discussion due to both positive effects (reduced risk of cardiovascular disease) and negative effects (increased risk of breast cancer). A paper published in the BMJ Group's Journal of Family Planning and Reproductive Healthcare back in January cast doubt on the "unreliable" Million Women Study which associated HRT with an increased risk of breast cancer.

Conflicting results have led clinicians to believe that time since menopause until HRT is initiated can account for differences in cardiovascular outcome. So authors from Denmark carried out a over 10 years with additional six years of follow-up to establish whether HRT can reduce if it is started early after menopause.

1006 women (504 in HRT group and 502 in non-HRT group) were included in the study and all were white, healthy, recently menopausal and aged 45-58 years old. Women who'd had a hysterectomy were only included if they were aged 45-52. Exclusion criteria were if they had a history of , uncontrolled chronic disease, previous or current cancer, current or previous use of HRT within the past three months and alcohol or . All data on diagnoses or death were taken from the Danish Civil Registration System and National Register. The primary end-point was a combination of death and hospitalisation for a heart attack or .

After 10 years of randomised treatment the women were encouraged to discontinue the use of HRT due to the results from the Women's Health Initiative and the Million Women Study. During this period, 26 women in the non-HRT group died and 33 died or experienced a cardiovascular end-point, compared to 15 deaths and 16 deaths or cardiovascular end-points in the HRT group.

The women were followed for another six years. During this time, the primary end-point was seen in 53 women in the non-HRT group (40 deaths, eight heart failures and five heart attacks) and 33 in the HRT group (27 deaths, three heart failures and three heart attacks).

Causes of death were 23 cardiovascular deaths and 17 non-cardiovascular deaths in the non-HRT group and six cardiovascular deaths and 21 non-cardiovascular deaths in the HRT group.

The study also found that women who had undergone a hysterectomy and younger women taking HRT had a significantly reduced risk of death or .

The authors conclude that women treated with long term HRT early after menopause "had significantly reduced risk of mortality, heart failure, or myocardial infarction [], without any apparent increase of cancer, venous thromboembolisms [DVT] or stroke." However, they stress that "due to the potential time lag longer time may be necessary to take more definite conclusions."

More information: www.bmj.com/cgi/doi/10.1136/bmj.e6409

add to favorites email to friend print save as pdf

Related Stories

HRT increases likelihood of hip and knee replacement

Oct 28, 2008

(PhysOrg.com) -- Having more children and using hormone replacement therapy (HRT) increases the likelihood that women will have joint replacement surgery, a large Oxford University-led study has shown.

Recommended for you

First expert consensus on ventricular arrhythmias published

5 hours ago

The first expert consensus on ventricular arrhythmias is published today. The novel document compiles current evidence on the diagnosis and management of ventricular arrhythmias and was agreed by international experts from ...

'Face time' for the heart diagnoses cardiac disease

Aug 29, 2014

To the careful observer, a person's face has long provided insight into what is going on beneath the surface. Now, with the assistance of a web camera and software algorithms, the face can also reveal whether or not an individual ...

User comments